EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19

Clinical trial NCT04822818 · COMPLETED

Trial details

NCT number: NCT04822818
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Corona Virus Infection SARS (Severe Acute Respiratory Syndrome)Virus Diseases Coronaviridae Infections Nidovirales Infections RNA Virus Infections Respiratory Tract Infections Respiratory Tract Diseases

Start date: 2021-04-17
Primary completion: 2022-04-10
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.